Fentanyl: What It Is and Why It Is So Dangerous
Fentanyl is a synthetic opioid roughly 100 times more potent than morphine and 50 times more potent than heroin, prescribed in hospital settings for surgical anesthesia and for severe pain. Illicitly manufactured fentanyl now drives the majority of opioid overdose deaths in the United States.
This page covers what fentanyl is and why appearance tells a person nothing useful about potency. It also covers why the dose margin is so unforgiving, how dependence and withdrawal compare with other opioids, and what harm reduction achieves.
Key Takeaways
- Fentanyl is approximately 50 times more potent than heroin and 100 times more potent than morphine, according to the US Drug Enforcement Administration.
- 88% of the opioid-involved overdose deaths in the United States in 2024 involved fentanyl or another synthetic opioid, according to CDC NCHS.
- Appearance carries no usable information about potency. Counterfeit tablets are pressed to imitate legitimate pharmaceuticals, and powders vary in color without that color meaning anything.
- Fentanyl-involved overdose deaths in Montana rose from a rate too low to calculate before 2020 to 8.9 per 100,000 residents in 2023.
- Fentanyl withdrawal begins sooner and can feel more abrupt than heroin withdrawal because of fentanyl's short duration of action, though the syndrome itself is the same.
If you need help now
For a medical emergency, including a suspected overdose or a withdrawal seizure, call 911.
For a mental health or suicide crisis, the 988 Suicide and Crisis Lifeline is free, confidential and available 24 hours a day. Call 988, text 988, or chat online at 988lifeline.org. Spanish-language support is available by calling 988 and pressing 2 or by texting AYUDA to 988. Deaf and hard of hearing callers can connect through ASL by using the videophone option at 988lifeline.org.
Substance use disorders are treatable conditions. Most people who receive treatment improve, and returning to use after a period of abstinence is a common part of the course of the illness rather than a sign that treatment has failed.
What is fentanyl?
Fentanyl is a synthetic opioid analgesic that acts on mu-opioid receptors, approximately 100 times more potent than morphine and 50 times more potent than heroin. It is prescribed for surgical anesthesia and severe pain, and manufactured illicitly for the unregulated drug supply.
Two facts about fentanyl explain nearly everything else. The first is potency, which means the difference between an active dose and a fatal dose is measured in a quantity too small to see or divide reliably outside a laboratory. The second is that fentanyl is cheap to synthesize and easy to transport, which is why it displaced heroin across most of the American drug supply rather than sitting alongside it.
Those two facts combine into a third. Most people who die from fentanyl did not decide to take fentanyl. They took something they believed to be a prescription tablet, or cocaine, or heroin, and fentanyl was in it. The intent to use a drug and the intent to use that drug have come apart, and overdose prevention has had to change accordingly.
Pharmaceutical fentanyl and illicitly manufactured fentanyl are the same molecule used in entirely different conditions. Pharmaceutical fentanyl is dosed in micrograms by clinicians, delivered through transdermal patches, lozenges or intravenous infusion, and given to patients whose opioid tolerance is known. Its use in hospital is routine and safe.
Illicitly manufactured fentanyl carries none of those controls. It is synthesized without quality control, mixed by hand, and distributed without any reliable relationship between what a unit is labeled and what it contains. The DEA reports fentanyl at roughly 50 times the potency of heroin. The quantity separating an active dose from a lethal one is therefore smaller than can be measured with the equipment available in an informal setting.
Fentanyl also has a family. Chemists produce structural analogues that vary in potency, some far exceeding fentanyl itself, and the most extreme of these analogues is carfentanil.
A separate complication is the veterinary sedative xylazine, known as tranq, which is not an opioid, does not respond to naloxone and now appears mixed into the fentanyl supply.
What does fentanyl look like?
Fentanyl has no reliable appearance. It is pressed into counterfeit tablets made to imitate legitimate prescription medicines, and it appears as powder in a range of colors. Neither the form nor the color indicates whether fentanyl is present or how much.
This is the useful answer rather than an evasion of the question. People search for what fentanyl looks like to avoid it, and the honest finding from forensic testing is that visual inspection cannot achieve that. Counterfeit tablets are manufactured with the same imprints, colors and shapes as legitimate pharmaceuticals, using commercial pill presses. A tablet that looks exactly like a prescription opioid or a prescription benzodiazepine is not thereby a prescription anything.
The practical point
Two tablets pressed from the same batch can contain markedly different amounts of fentanyl, because powder mixed by hand does not distribute evenly. This is often called the chocolate chip cookie problem. Consistency of appearance says nothing about consistency of dose, so the fact that an earlier tablet from the same source caused no harm carries no protective information about the next one.
Powder fentanyl has been recovered in white, off-white, tan, brown, blue and other colors. The color is a function of what the fentanyl was cut with and of dye added during manufacture. It is a marketing feature, not a potency label, and treating any color as safer than another has no basis.
What this means in practice is that identification is not the protective step people hope it is. Chemical testing detects presence, which is a different question from quantity, and the limits of that are covered later on this page and on the page on fentanyl test strips. The reason identification matters so much is the size of the margin for error.
Why is fentanyl so dangerous?
Fentanyl is dangerous for three reasons: its potency compresses the margin between an active dose and a fatal one, its supply carries an unknown and uneven dose, and it depresses respiration fast. Respiratory depression arrives faster than most people recognize.
Overdose warning
Fentanyl overdose stops breathing, often within minutes. Naloxone reverses it, and multiple doses are frequently required. Call 911 for any suspected overdose, give naloxone if it is available, and stay with the person until help arrives.
Every opioid kills by the same mechanism. Mu-opioid receptors in the brainstem regulate the drive to breathe, and sufficient opioid suppresses that drive until breathing stops. Fentanyl is not more toxic than other opioids at equivalent effect. It reaches that suppressing quantity in a far smaller amount of substance, and it reaches it quickly.
Speed changes the outcome. Fentanyl crosses the blood-brain barrier rapidly because it is highly lipophilic, so the interval between administration and respiratory depression is shorter than with heroin. Bystanders have less time to notice and respond. Fentanyl also produces chest wall rigidity at high doses, which further impedes breathing.
The scale of this is visible in the mortality data. CDC NCHS recorded 80,391 overdose deaths in the United States in 2024. Opioids were involved in 68% of them, and fentanyl or another synthetic opioid was involved in 88% of those opioid deaths. Even as total overdose deaths fell 26.9% between 2023 and 2024, synthetic opioids remained the dominant agent.
- 50x more potent than heroin (US DEA)
- 88% of 2024 US opioid overdose deaths involved fentanyl or another synthetic opioid (CDC NCHS Data Brief 549)
- 8.9 Montana fentanyl overdose deaths per 100,000 in 2023, from a rate too low to calculate before 2020 (Montana DPHHS, 2024)
Montana's trajectory shows how recently this arrived. The Montana Department of Public Health and Human Services could not calculate a fentanyl overdose death rate for the state before 2020 because the counts were too small. The rate was 2.7 per 100,000 residents in 2020 and 8.9 per 100,000 in 2023, more than tripling in three years. A person who formed their sense of the local drug supply before 2020 is working from an obsolete picture.
How does fentanyl dependence and withdrawal differ from other opioids?
Fentanyl produces the same opioid withdrawal syndrome as heroin or prescription opioids, but it begins sooner and can feel more abrupt because of fentanyl's short duration of action. Fentanyl also accumulates in fatty tissue, which extends withdrawal for some people beyond the expected window.
The symptoms themselves are not distinctive. Muscle and bone aching, cramping, diarrhea, vomiting, sweating, gooseflesh, dilated pupils, insomnia, restlessness and severe anxiety appear in fentanyl withdrawal exactly as they do in withdrawal from any other opioid. All are scored with the same Clinical Opiate Withdrawal Scale.
Two features do differ. Onset is earlier, because fentanyl's analgesic action is short, so a person using illicit fentanyl frequently experiences withdrawal several times a day rather than once. That pattern drives extremely frequent dosing and makes the dependence feel relentless in a way that longer-acting opioids do not.
The second feature is lipophilicity. Fentanyl distributes into fatty tissue and releases back into circulation slowly, so in people with sustained heavy use the drug can be detectable and withdrawal can persist longer than the textbook 5 to 10 days. Elimination timing is covered on the page on how long fentanyl stays in your system.
Tolerance behaves as it does with every opioid, and the consequence is the same. It falls within days of stopping, so returning to a previously routine quantity after detox, custody or hospital admission is the highest-risk moment in the entire course of the disorder. The general mechanism is set out on the page on opioid addiction, its signs, effects and withdrawal.
What can fentanyl testing and harm reduction do, and what can they not do?
Fentanyl test strips detect whether fentanyl is present in a sample and cannot measure how much. Naloxone reverses opioid overdose and frequently needs repeated doses against fentanyl. Neither measure treats opioid use disorder, and both reduce deaths among people who are still using.
The following are what each harm reduction measure achieves and where it stops.
| Measure | What it does | What it cannot do |
|---|---|---|
| Fentanyl test strips | Detect the presence of fentanyl in a dissolved sample | Quantify the dose, or detect uneven distribution within a batch |
| Naloxone | Displace opioids from mu receptors and restore breathing | Reverse a non-opioid such as xylazine, or work without someone present to give it |
| Never using alone | Ensure someone is present who can call 911 and give naloxone | Prevent the overdose itself |
| Withdrawal management | End physical dependence safely | Treat the disorder, or protect against the tolerance loss that follows |
The limitation on test strips deserves emphasis because it is routinely misunderstood. A positive result is informative and a negative result is weak evidence, since uneven mixing means the portion tested may not represent the portion consumed. Test strips shift the odds. They do not make an unregulated supply safe.
Naloxone's limitation with fentanyl is dosing. Fentanyl binds tightly and multiple naloxone doses are frequently required, so a single administration that produces no response is not evidence that opioids were not involved. Practical guidance is on the page on Narcan and naloxone. Montana distributed over 78,000 naloxone kits in 2023, according to Montana DPHHS.
Two investigational approaches aim at fentanyl specifically. Bremer and colleagues reported that the monoclonal antibody CSX-1004 binds fentanyl in the bloodstream before it reaches the mu-opioid receptor, and it has reached phase 1 testing in humans. An anti-fentanyl vaccine developed at the University of Houston entered phase 1 and 2 trials in 2026 with 40 participants. Neither is approved, and neither replaces naloxone.
Harm reduction and treatment are not competing approaches. Harm reduction keeps a person alive during the period in which they are not yet ready or able to enter treatment, and a person who dies of overdose never enters treatment at all. Treatment addresses the disorder that produced the exposure in the first place.
New Frontier Recovery Center provides medically supervised detox at ASAM Level 3.7 and residential treatment at ASAM Level 3.5 for adults with substance use disorders in Huntley, Montana. To read how withdrawal management is delivered and what admission involves, see our fentanyl treatment program.
About this page
New Frontier Recovery Center publishes this material for general education. It does not replace assessment by a licensed clinician.
Frequently asked questions
How much stronger is fentanyl than heroin?
Can you tell if a pill contains fentanyl by looking at it?
Why do fentanyl overdoses need more than one dose of naloxone?
Does fentanyl withdrawal last longer than heroin withdrawal?
Can you overdose on fentanyl by touching it?
Do fentanyl test strips make drug use safe?
Is fentanyl in drugs other than opioids?
How common is fentanyl in Montana?
Sources
- US Drug Enforcement Administration. Public safety alert on carfentanil, 22 September 2016, and DEA drug fact sheets. Relative potency of fentanyl against heroin and morphine.
- Centers for Disease Control and Prevention, National Center for Health Statistics. Drug Overdose Deaths in the United States, 2023-2024, NCHS Data Brief 549. Total overdose deaths, opioid share and synthetic opioid share.
- Montana Department of Public Health and Human Services (2024). Drug Overdose Deaths in Montana 2014-2023. Montana fentanyl-involved overdose death rates by year.
- Montana Department of Public Health and Human Services (2025). Opioid Use in Montana. Naloxone distribution and state opioid overdose figures.
- Wesson, Donald R. and Ling, Walter (2003). The Clinical Opiate Withdrawal Scale (COWS), Journal of Psychoactive Drugs. Withdrawal severity scoring applied across opioids including fentanyl.
- Nallani, S. C. et al. (2025). FDA Approval Summary: Nalmefene Nasal Spray for the Emergency Treatment of Known or Suspected Opioid Overdose, Clinical Pharmacology and Therapeutics, 117(3), 620-626. Approval basis and pharmacology of the 2023 nalmefene approval.
- Bremer, P. T. et al. (2023). Investigation of monoclonal antibody CSX-1004 for fentanyl overdose, Nature Communications, 14, 7700. Preclinical and early-phase data on fentanyl-specific monoclonal antibodies.